TABLE 2.

Plasma fatty acids from total phospholipids of control and n-3 LCPUFA-supplemented animals

	Control (n = 6)	Fish Oil (n = 6)
Fatty acidsa	g/100 gb
12:0	0.6 ± 0.2	2.1 ± 0.2
16:0	25.0 ± 0.5	27.3 ± 0.4 *
18:0	16.8 ± 0.7	14.1 ± 0.2 *
Σ Saturated	43.1 ± 0.0	44.5 ± 0.4
18:1 n-9	9.8 ± 0.1	6.8 ± 0.3 *
18:1 n-7	1.6 ± 0.0	1.5 ± 0.1
Σ Monounsaturated	11.4 ± 0.0	8.3 ± 0.3 *
18:2 n-6	12.9 ± 1.1	8.6 ± 0.6 *
20:4 n-6c	15.9 ± 0.2	9.4 ± 0.7 *
22:4 n-6	1.8 ± 0.3	0.2 ± 0.1
22:5 n-6	1.9 ± 0.3	0.3 ± 0.0
Σ n-6 Polyunsaturated	34.8 ± 0.7	19.3 ± 1.2 *
18:3 n-3	0.1 ± 0.0	0.1 ± 0.0
20:3 n-3	0.0 ± 0.0	0.1 ± 0.0
20:4 n-3	0.1 ± 0.1	0.1 ± 0.0
20:5 n-3d	0.2 ± 0.1	4.9 ± 0.4 *
22:5 n-3	1.8 ± 0.2	5.1 ± 0.6 *
22:6 n-3e	5.7 ± 0.7	16.4 ± 0.5 *
Σ ω3 Polyunsaturated	7.9 ± 0.8	26.7 ± 0.8 *

^aMinor fatty acids [14:0, 15:0, 17:0, 19:0, 20:0, 22:0, 24:0, 14:1(n-5), 16:1(n-9), 20:1(n-7), 20:1(n-11), 22:1(n-7), 24:1(n-11), 24:1(n-7), 20:3(n-9), and 22:3(n-9)] are not reported because they represented <0.3% of total fatty acids.

^bValues are means ± SEM, n = 6. Asterisk indicates significant differences between dietary treatments with P < 0.01.

^c20:4 n-6, AA.

^d20:5 n-3, EPA.

^e22:6 n-3, DHA.